Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SRDX - SurModics - Biotech IPO -- Ignore unavailable to you. Want to Upgrade?

To: Donald carlson who wrote (14)	7/2/1998 6:35:00 PM
From: lindend	Read Replies (1) \| Respond to of 84

>There isn't much of a track record for making a credible growth projection. > Thanks for the info. I've learned a painful lesson with recent IPO stocks and PEG + P/E ratios. Quality new issues can't be judged solely on these ratios, especially if earnings/revenues are accelerating. I was waiting on ARMHY's P/E and PEG to get in line before I bought it, and as I waited, the stock doubled in a two weeks. Not going to make the same mistake with SRDX.